Literature DB >> 19585455

Impact of CT based attenuation correction on quantitative assessment of DaTSCAN ((123)I-Ioflupane) imaging in diagnosis of extrapyramidal diseases.

Małgorzata Bieńkiewicz1, Magdalena Górska-Chrzastek, Jakub Siennicki, Agata Gajos, Andrzej Bogucki, Alina Mochecka-Thoelke, Anna Płachcińska, Jacek Kuśmierek.   

Abstract

The quality of visually and semi-quantitatively assessed DaTSCAN images is crucial for differential diagnostics of extrapyramidal diseases. Neuroimaging with the use of presynaptic tracers of the dopaminergic system provides evidence of nigrostriatal degeneration and may support the clinical diagnosis of Parkinsonism. During the last two years (2007-2008) we tried to elaborate the optimal methodology of SPECT/CT examination with the use of DaTSCAN ((123)I-Ioflupane), and we sought to evaluate the effect of the reconstruction and attenuation correction method on semi-quantitative measures of relative uptake in the striatum. In a present study, we retrospectively studied DaTSCAN scans of 44 consecutive patients with clinical indications of Parkinson's disease or uncertain Parkinsonian syndromes. The quality of DaTSCAN images reconstructed with the use of ordered-subset expectation maximization reconstruction technique (OSEM) with attenuation correction based on CT maps was found to be superior to that provided by the commonly applied filtered backprojection method (FBP) with Chang attenuation correction. OSEM reconstructed transverse slices were more legible for clinical interpretation because of increased contrast and improved delineation between striatum structures. Semi-quantitative assessments of relative striatum uptake for OSEM reconstructed slices secured better intra-operator reproducibility than that obtained by FBP method.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19585455

Source DB:  PubMed          Journal:  Nucl Med Rev Cent East Eur        ISSN: 1506-9680


  6 in total

1.  Influence of CT-based attenuation correction on dopamine transporter SPECT with [(123)I]FP-CIT.

Authors:  Constantin Lapa; Timo S Spehl; Joachim Brumberg; Ioannis U Isaias; Susanne Schlögl; Michael Lassmann; Ken Herrmann; Philipp T Meyer
Journal:  Am J Nucl Med Mol Imaging       Date:  2015-02-15

2.  A new quantitative index in the diagnosis of Parkinson syndrome by dopamine transporter single-photon emission computed tomography.

Authors:  Ryota Bando; Hideki Otsuka; Tamaki Otani; Noritake Matsuda; Shota Azane; Yamato Kunikane; Yoichi Otomi; Wataru Sako; Yuishin Izumi; Masafumi Harada
Journal:  Ann Nucl Med       Date:  2021-02-25       Impact factor: 2.668

3.  Acquisition count dependence of the specific binding ratio in 123I-FP-CIT SPECT.

Authors:  Akinobu Kita; Hidehiko Okazawa; Katsuya Sugimoto; Ryoto Kaido; Nobuyuki Kosaka; Takayuki Shibutani; Masahisa Onoguchi; Eiji Kidoya; Hirohiko Kimura
Journal:  Ann Nucl Med       Date:  2021-08-10       Impact factor: 2.668

4.  CT-based attenuation correction in I-123-ioflupane SPECT.

Authors:  Catharina Lange; Anita Seese; Sarah Schwarzenböck; Karen Steinhoff; Bert Umland-Seidler; Bernd J Krause; Winfried Brenner; Osama Sabri; Jens Kurth; Swen Hesse; Ralph Buchert
Journal:  PLoS One       Date:  2014-09-30       Impact factor: 3.240

5.  Evaluation of Iterative Reconstruction Method and Attenuation Correction in Brain Dopamine Transporter SPECT Using an Anthropomorphic Striatal Phantom.

Authors:  Akira Maebatake; Ayaka Imamura; Yui Kodera; Yasuo Yamashita; Kazuhiko Himuro; Shingo Baba; Kenta Miwa; Masayuki Sasaki
Journal:  Asia Ocean J Nucl Med Biol       Date:  2016

6.  Attenuation and scatter correction in I-123 FP-CIT SPECT do not affect the clinical diagnosis of dopaminergic system neurodegeneration.

Authors:  Miho Akahoshi; Koichiro Abe; Yumiko Uchiyama; Mitsuru Momose; Kenji Fukushima; Kazuo Kitagawa; Shuji Sakai
Journal:  Medicine (Baltimore)       Date:  2017-11       Impact factor: 1.817

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.